Keimyung University Dongsan Hospital Earns 11th Straight Top Rating for Acute Stroke Care
Keimyung University Dongsan Hospital announced on August 3 that it received the top Grade 1 rating in the Health Insurance Review & Assessment...
Full Article(1000)
Samsung Medical Center Adopts Next-Generation Da Vinci 5 Robot to Advance Lung and Esophageal Cancer Surgery
Samsung Medical Center has introduced the latest robot-assisted surgery platform, the Da Vinci 5, for lung and esophageal cancer operations.
Inha University Hospital Earns Perfect Score in Acute Stroke Evaluation, Securing Top Grade for 11th Straight Time
Inha University Hospital posted a perfect score of 100 in a national assessment of acute stroke care, securing the...
How to Prevent Food Poisoning on Vacation: Handle Eggs and Raw Meat with Care
Peak summer vacation season is in full swing. While it is a time to unwind, it is also a period when people need to be...
Quercetin Fights Inflammation: 3 Foods Packing More of the Antioxidant Than Onions
Free radicals are unstable molecules that drive internal inflammation, accelerate cellular aging, and heighten the risk...
BLACKPINK’s Jennie Sparks Summer Lavender Makeup Trend in Spain: How to Get the Look
At the recent Mad Cool Festival held in Madrid, Spain, BLACKPINK’s Jennie took the main stage as a headlining...
Can You Take Too Many Supplements? Symptoms That Signal You Are Overdoing It
Supplements can be a convenient way to fill nutritional gaps, but consuming more than your body needs can harm your...
Daegu Fatima Hospital Scores 99.96 in National Stroke Assessment, Outperforming Top-Tier Centers
Daegu Fatima Hospital has earned Grade 1 ratings across three key medical quality evaluations conducted by the Health...
Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2
South Korea’s five major legacy pharmaceutical companies largely extended their revenue growth in the second quarter,...
Scalp-Injected RNA Hair Loss Drug Completes Phase 1b Dosing in Australia
OliX announced on August 4 that it has completed patient dosing in the Australian Phase 1b clinical trial for OLX104C...